Monitoring of patients with COPD: A review of current guidelines' recommendations

Respiratory Medicine

Volumn 102, Issue 5, 2008, Pages 633-641

  van den Bemt, Lisette ^a   Schermer, Tjard ^a   Smeele, Ivo ^b,c   Bischoff, Erik ^a   Jacobs, Annelies ^a   Grol, Richard ^a   van Weel, Chris ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SHL (Diagnostic Centre Breda)   (Netherlands)

^c General Practitioners' Advisory Group for COPD and Asthma (CAHAG)   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Clinical practice guideline; Monitoring

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; EXERCISE TOLERANCE; FOLLOW UP; HUMAN; LUNG FUNCTION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMOKING HABIT;

COMORBIDITY; EVIDENCE-BASED MEDICINE; EXERCISE TOLERANCE; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 41149133780     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.12.014     Document Type: Review

References (54)

1. Walke L.M., Gallo W.T., Tinetti M.E., and Fried T.R. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 164 21 (2004) 2321-2324
2. Glasziou P., and Haynes B. The paths from research to improved health outcomes. ACP J Club 142 2 (2005) A8-A10
3. Jones P.W., and Agusti N. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Resp J 27 (2006) 822-832
4. Grol R., Cluzeau F.A., and Burgers J.S. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer 89 Suppl. 1 (2003) S4-S8
5. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 〈www.goldcopd.com〉 [accessed January 2007].
6. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 Suppl. I (2004) i1-i232
7. Dekhuijzen P.N.R., Smeele I.J.M., Smorenburg S.M., and Verhoeven M.A.W.M. Richtlijn ketenzorg COPD (2005), Van Zuiden Communications BV, Alphen aan de Rijn
8. American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD, 〈http://www.ersnet.org〉 [accessed October 2006].
9. van den Bemt L., Schermer T., and van Weel C. Rational monitoring of COPD: where do current clinical guidelines stand?. Eur Respir J 29 6 (2007) 1078-1081
10. Online medical dictionary, 〈http://cancerweb.ncl.ac.uk/omd/〉 [accessed November 2006].
11. Health plan of Nevada COPD guidelines (Chronic Obstructive Pulmonary Disease), 〈http://www.healthplanofnevada.com/〉 [accessed October 2006].
12. Kinnula V. Evidence-based medicine guideline; chronic obstructive pulmonary disease, 〈www.ebm-guidelines.com〉 [accessed July 2006].
13. International Primary Care Airways Group. IPAG-handbook chronic airways diseases: a guide for primary care physicians, 〈www.globalfamilydoctor.com/pdfs/IPAGHandbook.pdf〉 [accessed October 2006].
14. Bellamy D., Bouchard J., Henrichsen S., Johansson G., Langhammer A., Reid J., et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 15 1 (2006) 48-57
15. The Australian Lung Foundation, The Thoracic Society of Australia and New Zealand. Chronic obstructive pulmonary disease (COPD) Australian and New Zealand management guidelines and the COPD handbook (COPD-X), 〈www.copdx.org.au/guidelines/index.asp〉 [accessed July 2007].
16. Smeele I.J.M., Van Weel C., Van Schayck C.P., Van der Molen T., Thoonen B., Schermer T., et al. NHG-standaard COPD; tweede herziening. Huisarts Wet 50 (2007) 362-379
17. Shahin S., Attar H., Eshtawy J., et al. Palestinian guideline for diagnosis and management of chronic obstructive pulmonary disease. Quality improvement program (2003), Ministry of Health, Palestine
18. CKS Chronic Obstructive Pulmonary Disease (PRODIGY Guidance). Clinical knowledge summaries service version 1.0.0 last revised in august 2007, 〈www.cks.library.nhs.uk/chronic_obstructive_pulmonary_disease〉 [accessed November 2007].
19. Institute for Clinical System Improvement (ICSI). Health care guideline; chronic obstructive pulmonary disease, 〈www.icsi.org/index.asp〉 [accessed July 2007].
20. American Broad of Family Practice (ABFP). Reference guide COPD [accessed October 2004].
21. Canadian Thoracic Society. Executive summary Canadian Thoracic Society. Recommendations for management of chronic obstructive pulmonary disease, 〈www.pulsus.Com/respir/10_SA/contents〉 [accessed October 2006].
22. O'Donnell D.-E., Aaron S., Bourbeau J., et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 10 Suppl. A (2003) 11A-65A
23. British Columbia Medical Association (BCMA). GPAC: Guidelines and Protocols Advisory Committee. Chronic obstructive pulmonary disease (COPD), 〈www.health.gov.bc.ca/msp/protoguides/gps/copd.pdf〉 [accessed July 2007].
24. Jindal S.K., Gupta D., and Aggarwal A.N. Guidelines for management of chronic obstructive pulmonary disease (COPD) in India: a guide for physicians (2003). Indian J Chest Dis Allied Sci 46 2 (2004) 137-153
25. Bateman E.-D., Feldman C., O'Brien J., Plit M., and Joubert J.-R. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. S Afr Med J 94 7 Part 2 (2004) 559-575
26. Russi E.-W., Leuenberger P., Brandli O., et al. Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society. Swiss Med Wkly 132 5-6 (2002) 67-78
27. Harbour R., and Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 323 7308 (2001) 334-336
28. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., and Connett J.E. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142 4 (2005) 233-239
29. Willemse B.W., Postma D.S., Timens W., and ten Hacken N.H. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23 3 (2004) 464-476
30. van der Meer R.M., Wagena E.J., Ostelo R.W., Jacobs J.E., and van Schayck C.P. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2 (2003) CD002999
31. Sestini P., Renzoni E., Robinson S., Poole P., and Ram F.S. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4 (2002) CD001495
32. Kanner R.E., Connett J.E., Williams D.E., and Buist A.S. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 106 4 (1999) 410-416
33. Bendstrup K.E., Ingemann J.J., Holm S., and Bengtsson B. Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 10 12 (1997) 2801-2806
34. Bourbeau J., Julien M., Maltais F., et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 163 5 (2003) 585-591
35. Alsaeedi A., Sin D.D., and McAlister F.A. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 113 1 (2002) 59-65
36. Burge P.S. Prevention of exacerbations: how are we doing and can we do better?. Proc Am Thorac Soc 3 3 (2006) 257-261
37. Vincken W., Van Noord J.A., Greefhorst A.P., et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 19 2 (2002) 209-216
38. Miravitlles M., Ferrer M., Pont A., et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 59 5 (2004) 387-395
39. Seemungal T.A.R., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
40. Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 97 Suppl. C (2003) S3-S14
41. Wilkinson T.M., Donaldson G.C., Hurst J.R., Seemungal T.A., and Wedzicha J.A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 12 (2004) 1298-1303
42. Hesselink A.E., Penninx B.W., Wijnhoven H.A., Kriegsman D.M., and van Eijk J.T. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care 19 4 (2001) 255-260
43. Hesselink A.E., Penninx B.W.J.H., Windt D.A.W.M.V.D., et al. Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomised controlled trial. Patient Educ Couns 55 (2004) 121-128
44. van der Palen J., Klein J.J., and Rovers M.M. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 10 3 (1997) 652-657
45. Rutten F.H., Cramer M.J., Grobbee D.E., et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26 18 (2005) 1887-1894
46. Decramer M., Gosselink R., Rutten-van Molken M., et al. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax 60 4 (2005) 335-342
47. de Torres J.P., Pinto-Plata V., Ingenito E., et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121 (2002) 1092-1098
48. Celli B.R., Cote C.G., Marin J.M., et al. the body-mass indexed airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 10 (2004) 1005-1012
49. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 6 Part 1 (1998) 1791-1797
50. Katsura H., Yamada K., and Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 99 5 (2005) 624-630
51. Ferreira I.M., Brooks D., Lacasse Y., Goldstein R.S., and White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 1 (2002) CD000998
52. Jones P.W., Willits L.R., Burge P.S., and Calverley P.M.A. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 21 (2003) 68-73
53. Hoogendoorn M., Feenstra T.L., Schermer T.R., Hesselink A.E., and Rutten-van Molken M.P. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 100 (2006) 83-86
54. The AGREE Collaboration. Appraisal of Guidelines Research and Evaluation (AGREE) Instrument, 〈www.agreecollaboration.org〉 [accessed November 2006].